Related Experiment Video
Updated: Sep 23, 2025
10:28
Reusable Single Cell for Iterative Epigenomic Analyses
Published on: February 11, 2022
1.4K
Developments in high-throughput functional epigenomics: CRISPR-single-cell assay for transposase-accessible chromatin
Rachel E Yan1, Jeffrey P Greenfield1, Nadia Dahmane1
1Weill Cornell Medical College, Department of Neurological Surgery, New York, NY 10021, USA.
Epigenomics
|May 16, 2022
Summary
CRISPR-scATAC-seq screens enable high-throughput functional epigenomics. This method links genetic perturbations to epigenetic states and accessible DNA sequences for deeper biological insights.
Area of Science:
- Genomics
- Epigenetics
- Molecular Biology
Background:
- CRISPR-based screening is a powerful tool for functional genomics.
- Single-cell Assay for Transposase-Accessible Chromatin using sequencing (scATAC-seq) provides genome-wide epigenetic information at single-cell resolution.
Discussion:
- CRISPR-scATAC-seq screens integrate CRISPR perturbations with scATAC-seq data.
- This approach allows for the analysis of epigenetic changes induced by specific genetic modifications in individual cells.
Key Insights:
- The study introduces CRISPR-scATAC-seq as a method for high-throughput functional epigenomics.
- It demonstrates the ability to link genetic perturbations to broad epigenetic states and sequence accessibility.
- This enables the discovery of regulatory elements and their roles in cellular function.
Outlook:
- CRISPR-scATAC-seq screens are expected to accelerate the understanding of gene regulation and epigenetic mechanisms.
- Future applications may include disease modeling and drug discovery by dissecting epigenetic dysregulation.
